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Objective. The aim of this study was to identify patients with Parkinson’s disease who showed loss or decrease of nocturnal blood
pressure fall (nondipper patients) as a marker of autonomic dysfunction. Presence or absence of orthostatic hypotension was
considered to investigate whether alterations in circadian blood pressure pattern are associated with posture-related dysregulation
of blood pressure. Methods. 40 patients with Parkinson’s disease underwent 24-hour blood pressure monitoring. 21 patients
were diagnosed with arterial hypertension and received anti-hypertensive drugs. Nondipper patients were deﬁned as having
nocturnaldecreaseofmeansystolicanddiastolicbloodpressurelessthan10%.Presenceorabsenceoforthostatichypotensionwas
determined by Schellong’s test. Results. We identiﬁed 35 nondipper patients (88%). Nondipping was detected in 20 patients with
orthostatic hypotension (95%) and in 15 patients without orthostatic hypotension (79%). 18 patients with hypertensive and 22
patients with normal blood pressure values were detected. Conclusions. In conclusion 24-hour blood pressure monitoring showed
a high prevalence of nondipping in 40 patients with Parkinson’s disease with and without orthostatic hypotension independent
of coexisting arterial hypertension and antihypertensive treatment. 24-hour blood pressure monitoring may be useful to identify
non-dipping as a marker of autonomic dysfunction in patients with Parkinson’s disease.
1.Introduction
Parkinson’s disease is a multisystem degeneration [1]. Beside
motor symptoms, and psychiatric symptoms autonomic
dysfunction is a common ﬁnding in Parkinson’s disease [2].
Neuropathological studies showed the presence of Lewy
bodies in central and peripheral structures involved in
autonomic regulation [3–6].
Involvement of the autonomic nervous system (ANS)
occurs in the early stages of the disease [2].
Cardiovascular dysautonomia, especially orthostatic hy-
potension, is frequently reported in Parkinson’s disease [7].
Involvement of peripheral components of the ANS can
be demonstrated by MIBG scintigraphy.
MIBG scintigraphy shows reduced cardiac uptake of
MIBG (meta-[123I]iodobenzylguanidine) representing loss
of postganglionic myocardial sympathetic nerve ﬁbers in
patients with Parkinson’s disease and autonomic failure [8].
However these ﬁndings are also seen in the early stages of
the disease independent of symptoms of cardiovascular
dysautonomia [9].
Further eﬀects of autonomic cardiovascular dysfunction
are demonstrated in earlier studies such as baroreceptor
reﬂex dysfunction, alterations in circadian blood pressure
regulation, and supine hypertension [10–15]. Findings of
earlier reports on ambulatory blood pressure monitoring in
patients with Parkinson’s disease show a varying number of
patients with loss of nocturnal blood pressure fall [13–16].
Ambulatory blood pressure monitoring is frequently
used in the diagnosis and therapy monitoring of arterial
hypertension and allows an evaluation of the circadian blood
pressure evaluation [17, 18].
The aim of this study was to identify patients with
Parkinson’sdiseasewhoshowedlossordecreaseofnocturnal
blood pressure fall (non dipper patients) as a potential
marker of autonomic dysfunction.
Presence or absence of orthostatic hypotension was
considered to investigate whether alterations in circadian2 Parkinson’s Disease
Table 1: Characteristics of the population studied.
Variable Patients with PD
n = 40
Age, y 69,9 (8,6)
Sex, M/F 20/20
Disease duration, months 49 (42)
PD: Parkinson’s disease; mean values (SD).
blood pressure pattern are associated with posture-related
dysregulation of blood pressure.
2. Methods
patients with Parkinson’s disease underwent ambulatory
24-hour blood pressure monitoring. Parkinson’s Disease was
diagnosed according to the criteria of the United Kingdom
Parkinson’s disease Society Brain Bank [19]. None had
atypical features on neurological examination (e.g., cerebel-
lar, pyramidal) excluding diagnosis other than idiopathic
Parkinson’s disease (e.g., multiple system atrophy).
20 of the patients were male, 20 were female; they were
aged 41 to 82 years (mean age 69,9 years); disease duration
(Parkinson’s disease) was 1 to 152 months (mean disease
duration 49 months) (Table 1). 21 patients (53%) were
diagnosedwitharterialhypertensionandreceivedantihyper-
tensive drugs.
Long-term blood pressure measurements were per-
formed with “Mobilograph,” an oscillometric recorder
(I.E.M. GmbH, Stolberg, Germany). Patients were asked to
maintain their normal physical activity. Nondipper patients
were deﬁned as having nocturnal decrease of mean systolic
and diastolic blood pressure less than 10%. Presence or
absence of orthostatic hypotension was determined by
Schellong’s test (after resting in the supine position for 5 to
10 minutes the patient’s blood pressure and heart rate were
measured minute by minute for 3 minutes in the supine
position and for a total of 8 minutes in the upright position
after standing up rapidly); orthostatic hypotension was
deﬁned as a minimum decrease in systolic and/or diastolic
blood pressure of 20mmHg or 10mmHg, respectively, on
standing at the third minute [20]. Supine hypertension
was deﬁned as systolic and diastolic blood pressure above
140/90mmHg in the supine position [21].
2.1. Statistical Analysis. Results are presented as mean values
(± standard deviation (SD)). A correlation analysis was
performed between the presence of loss of nocturnal blood
pressure fall and disease duration, age and presence of
arterial hypertension/use of antihypertensive medication.
3. Results
Ambulatory blood pressure was recorded without interrup-
tion in all patients with a mean measurement period of 23
hours (± 1,8 hours). The average number of measurements
obtained during the 24-hour recording was 88% (± 11).
Table 2: Results of 24h ambulatory blood pressure monitoring.
Variable Patients with PD
n = 40
Cumulative measurement period, hours 23 (1,8)
Mean systolic BP, mmHg 130,3 (9)
Mean diastolic BP, mmHg 77,6 (6,7)
Day (8:00–22:00)
Mean systolic BP, mmHg 131,4 (10,2)
Mean diastolic BP, mmHg 78,7 (7,3)
Arterial Hypertension:
BD systol. > 140/90mmHg, % 45
Night (22:00–8:00)
Mean systolic BP, mmHg 129,6 (14,5)
Mean diastolic BP, mmHg 75,4 (9,2)
Pathologic mean nocturnal
BP: BP ≥ 125/80mmHg, % 63
Nocturnal BP
Non dipper patients, % 88 (n = 35)
Nocturnal increase of BP, % 43 (n = 17)
Mean systolic decrease of BP at night, % 0,9 (12,9)
Mean diastolic decrease of BP at night, % 3,9 (12,2)
PD: Parkinson’s disease; BP: blood pressure; mean values (SD).
Results of the mean diurnal arterial pressure showed
18 patients with hypertensive blood pressure values and 22
patients with normal blood pressure. Beside the 21 patients
who were already diagnosed with arterial hypertension
6 patients showed hypertensive blood pressure values in
ambulatory blood pressure recording; thus a total of 27
patients (68%) had arterial hypertension (Table 2).
We identiﬁed 35 non dipper patients (88%) among
40 examined patients with Parkinson’s disease; 25 patients
(63%) showed nocturnal increase of blood pressure
(Table 2). Correlation analysis found no correlation between
presence of loss of nocturnal blood pressure fall (non
dipper) and age, disease duration, and presence of arterial
hypertension or antihypertensive treatment.
Figure 1 gives an example of a 24-hour blood pressure
monitoringinapatientwithParkinson’sdiseaseshowingloss
of nocturnal blood pressure fall.
Autonomic test results showed 21 patients with ortho-
static hypotension. Loss of nocturnal blood pressure fall was
detected in 20 patients with orthostatic hypotension (95%);
this was also detected in 15 patients without orthostatic
hypotension (79%). We found 11 patients with supine
hypertension who were non dipper (100%) and 24 patients
without supine hypertension who were non dipper (83%)
(Table 3).
4. Discussion
We investigated ambulatory blood pressure monitorings in
patients with Parkinson’s disease to evaluate the circadian
blood pressure proﬁle, especially the presence or absence of
loss of nocturnal blood pressure fall (non dipper). ResultsParkinson’s Disease 3
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Figure 1: Example of a 24-hour ambulatory blood pressure recording in a patient with Parkinson’s disease.
Table 3: Autonomic test results (Schellong test).
Variable Patients with PD
n = 40
Orthostatic hypotension, % 53 (n = 21)
OH present + non dipper, % 95 (n = 20)
OH absent + non dipper, % 79 (n = 15)
Supine hypertension, % 28 (n = 11)
SH present + non dipper, % 100 (n = 11)
SH absent + non dipper, % 83 (n = 24)
PD: Parkinson’s disease, OH: orthostatic hypotension, SH: supine hyperten-
sion.
Table 4: Ambulatory blood pressure monitoring in patients with
Parkinson’s disease.
Reference Number of patients Nondipper (%)
[14] 13 92,3
[15]2 4 8 2
[16]2 3 4 8
[22]3 8 6 3
of earlier studies show a variable percentage of non dip-
per patients (Table 4), mainly observed in patients with
orthostatic hypotension [13–16]. Healthy controls were not
required because blood pressure dipping is well known in
healthy subjects [22].
Ourresultsshowthatmostofourexaminedpatientswith
Parkinson’s disease were non dipper (88%); this was even
found in 79% of the patients without orthostatic hypoten-
sion. In conclusion, ambulatory blood pressure monitoring
could be useful to detect autonomic dysfunction even in the
early stages of Parkinson’s disease when orthostatic hypoten-
sion is not present.
The alterations in the circadian blood pressure proﬁle
may be caused by impairment of the autonomic regulatory
mechanisms, possibly through postural dysregulation of
bloodpressureasmentionedinearlierreports[14].Thisdys-
regulation may produce supine hypertension and nondip-
ping particularly during the night when a supine position is
adopted. Furthermore a denervation supersensitivity of the
vascular α-adrenergic receptors due to sympathetic dener-
vation in patients with Parkinson’s disease may contribute
to supine hypertension during the night due to exaggerated
vasoconstriction [14, 23, 24].
Presence or absence of arterial hypertension was addi-
tionally investigated in our patients (anamnestic, results of
performed blood pressure recordings) to evaluate a possible
association with loss of nocturnal blood pressure fall; there
was no correlation between the presence of non-dipping and
the presence of arterial hypertension or use of antihyper-
tensive medication. 27 patients were additionally diagnosed
with arterial hypertension or had hypertensive blood pres-
sure values in ambulatory blood pressure recording (68%).
24-hourbloodpressuremonitoringshouldbeperformed
in patients with Parkinson’s disease and coexisting arterial
hypertension, who are treated with antihypertensive medi-
cation.
For prevention of an increased prevalence of end-organ
damage we propose treatment of nocturnal hypertension4 Parkinson’s Disease
in patients with Parkinson’s disease. Treatment with anti-
hypertensive drugs in patients with orthostatic hypotension
may be complicated by worsening of the postural blood
pressure fall in the upright position in these patients and
thus may cause syncopes or cerebral ischemia. Consequently,
vasoactive drugs should be used carefully in patients with
Parkinson’s disease and autonomic dysfunction. Alterna-
tively sleeping in a 12◦ head-up tilt position may be helpful
[25].
Concerning an increased cardio—and cerebrovascular
risk in patients with nondipping, Corn´ elissen et al. showed
that—compared with dipping—abnormal chronobiological
end points such as reduced circadian standard deviation
of heart rate or elevated pulse pressure are more useful to
discriminate between patients who are at a higher risk and
who are not [26]. However, to investigate the cardio- and
cerebrovascular risk in patients with Parkinson’s disease was
not aimed in our study.
In conclusion 24-hour ambulatory blood pressure mon-
itoring showed a high prevalence of non-dipping in 40
patients with Parkinson’s disease with and without ortho-
static hypotension independent of the coexisting arterial
hypertension, and antihypertensive treatment. Our data
strengthens the role of ambulatory blood pressure recording
fordetectionofnon-dipping notonlyinpatientswithortho-
static hypotension, but also in patients without orthostatic
hypotension. Beside other autonomic tests (Schellong’s test,
head-up tilt test) 24-hour blood pressure monitoring may be
helpful to support the detection of autonomic dysfunction
in patients with Parkinson’s disease even in the early stages of
the disease.
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